Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China Pulmonary Health Study
Jieping Lei(Chinese Academy of Medical Sciences & Peking Union Medical College), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Huahao Shen(Second Affiliated Hospital of Zhejiang University), Yuanlin Song(Zhongshan Hospital), Chunxue Bai(Fudan University), Kewu Huang(Capital Medical University), Sinan Wu(National Clinical Research Center for Digestive Diseases), Ting Yang(University Medical Center Groningen), Jianping Zhao(Xinjiang University), Pixin Ran(Guangzhou Experimental Station), Guangliang Shan(Chinese Academy of Medical Sciences & Peking Union Medical College), Ke Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingxiang Lin(Capital Medical University), Jian Kang(Seoul National University), Jianying Xu(Shanxi Dayi Hospital), Yongjian Xu(Ningbo University), Yahong Chen(Wenzhou Medical University), Xiangyan Zhang(Guizhou Provincial People's Hospital), Jianguo Zhu(Probiotical (Italy)), Fuqiandg Wen(Sichuan University), Wan-zhen Yao(Peking University Third Hospital), Tieying Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Yumin Zhou(National Clinical Research Center for Digestive Diseases)
Cited by 45
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
|Journal of Allergy and Clinical Immunology|2020|2.4k